Did you or a loved one experience uncontrolled bleeding or any complications while taking the blood thinner medication Xarelto?
If so, you may be eligible to receive compensation for your losses.
Approved by the Food and Drug Administration (FDA) in 2011, Xarelto is a blood thinner medication manufactured by Bayer and Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
As with all blood thinners, there is a risk of bleeding but that risk has been found to be exacerbated while taking Xarelto.
This medication is typically prescribed by cardiologists and hematologists for the treatment of blood clotting disorders, but it can also be prescribed in other circumstances, including:
- To treat atrial fibrillation (irregular heartbeat) and reduce the patient’s stroke risk;
- To prevent blood clots after a hip or knee replacement operation; and
- To treat blood clots forming as a result of pulmonary emobolus (PE) or deep vein thrombosis (DVT).
A number of Xarelto lawsuits have already been filed, with compensation sought to cover the medical bills and other financial hardships caused by serious internal bleeding, along with the costs of burial and a funeral for those who passed away as a result of the uncontrolled bleeding.
Lawsuit plaintiffs are also seeking compensation for emotional distress from experiencing internal bleeding or caring for a loved one who experienced this complication while taking Xarelto.
These serious complications have spurred many to file suit. In addition to bleeding problems, dangerous blood clots have also been reported to the FDA— a key finding because Xarelto is designed to thin the blood and prevent blood clots.
There is no antidote to Xarelto, making it extremely difficult to stop the bleeding that arises while taking this medication. This is a point of contention in many lawsuits, as many feel it was irresponsible for the company to release a product with no known antidote.
Many patients never received a warning about the dangerousness of Xarelto and the potential for serious and uncontrolled external and internal bleeding. A number of physicians indicated that they were never apprised of the real dangers of Xarelto.
Lawsuits have been filed in a number of states and the U.S. Judicial Panel has decided to consolidate these Xarelto lawsuit cases into a multi-district litigation (MDL) case. This means that all cases are handled in the same court.
Notably, Xarelto isn’t the only blood thinner that has been involved in lawsuits recently. A number of Pradaxa lawsuits have also been filed. It’s believed that Xarelto has similar bleeding risks as Pradaxa.